Oncology research has been slower to adopt digital clinical measures than other therapeutics specialties in healthcare and drug development. Thought leaders are working to reverse this trend and rapidly integrate digital clinical measures in oncology patient care and clinical research.
Hosted by Xtalks, Jeremy Wyatt, Chief Executive Officer at ActiGraph, and Kate Lyden, PhD., Chief Science Officer at VivoSense, join industry experts Heather Jim, Ph.D., Moffitt Cancer Center, Dr. Jorge Nieva, Keck Medicine at USC, and Dr. Ariel Aguilo, LabCorp Oncology Medical Team to discuss:
- The reasons behind and the missed opportunities from the slow adoption of these measures.
- Examples of successful deployment of wearable and remote monitoring technologies to improve clinical outcomes in cancer patients
{{cta(‘9720fa3e-97b7-4f8c-80da-a3ec439ac78e’)}}